HCLTech SmPC to PIL Conversion Module
HCLTech · Intelligence & Research
Certification per Microsoft Marketplace.
Evidence tier Source Confirmed · 7 captures on record
What the publisher says
As described on Microsoft Marketplace.
An agentic AI solution that converts Summary of Product Characteristics content into patient-friendly PIL drafts while supporting regulatory consistency, readability, and human review.
SmPC to PIL Conversion Agent helps life sciences organizations streamline the creation of Patient Information Leaflet drafts from Summary of Product Characteristics content. The solution is designed for regulatory affairs, labelling, medical writing, and compliance teams that need to convert technical product information into patient-facing content while maintaining alignment with approved source documents and applicable template expectations.
Show the rest of the publisher’s description (30 more lines)
Users can upload or select an SmPC document and generate a structured PIL draft based on the relevant sections, terminology, and approved product information. The agent interprets the SmPC content, transforms technical language into patient-readable text, and organizes the output into the expected PIL structure. The solution can support template-based generation, section-level mapping, readability checks, and review-ready outputs for downstream human validation.
The agentic workflow reduces manual drafting effort by using mapping agents to align SmPC sections with PIL sections, transformation agents to simplify technical language, consistency agents to check alignment with the source content, and review-support agents to highlight areas that may require human attention. Human users remain in control of review, approval, and final document release.
What the customer gets:
- Configured SmPC to PIL conversion agent for regulatory labelling use cases
- SmPC content extraction and section-mapping workflow
- Patient-friendly PIL draft generation based on source product information
- Template-based output structure, where applicable
- Section-level traceability between SmPC inputs and PIL output
- Readability support for patient-facing language
- Consistency checks against source content
- Review-ready draft output for human validation
- Downloadable PIL draft in required document format, where applicable
- User access, security, and governance design considerations
- User walkthrough, handover documentation, and deployment support
Expected business outcomes:
- Reduced manual effort in PIL draft preparation
- Faster conversion of technical product content into patient-facing language
- Improved consistency between SmPC and PIL content
- Better support for labelling review and compliance workflows
- Improved readability and traceability through section-level mapping
Competencies
- Agentic AI solution design
- Regulatory labelling and patient information content generation
- Life sciences regulatory affairs domain knowledge
- SmPC to PIL section mapping
- Patient-friendly medical content transformation
- Readability and consistency review workflows
- Generative AI document drafting and summarization
- Secure application architecture
- Human-in-the-loop review and governance
Preview
1 image
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Compliance
- FedRAMPConfirmedNot listed90%, registry-checkedNo FedRAMP Marketplace entry matched this vendor's domain, checked 2026-08-27registry recordas observed 2026-08-27
Confirmed means matched to a public authoritative registry. Claimed means the vendor or its listing states it, not yet cross-checked. A framework not shown was not found in any source we hold, which is not evidence against it. Not listed means a scoped registry check found no match for this vendor's domain: a No is a scoped registry check, not a compliance judgment. Confidence bands: 95% domain-verified, 90% registry-checked, 80% self-attested, 70% weak signal. Self-attested items marked “vendor's site” are gathered from the vendor's own website and are not verified by us.
Vendor
External enrichment · as of 2026-07-01
Sources
Publisher resources
2 linksLinked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.